Eliquis maker Bristol Myers Squibb sues over Medicare plan to cut drug costs
Washington Post
The pharmaceutical giant is challenging a provision in the Inflation Reduction Act that would let Medicare negotiate drug prices.
https://www.washingtonpost.com/business/2023/06/16/eliquis-bristol-myers-medicare-drugs/